Skip to main content
Log in

The role of adipose tissue as an endocrine gland

  • Invited Commentary
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aldahi W, Hamdy O:Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003, 3:293–298.

    Google Scholar 

  2. Yamauchi T, Kamon J, Ito Y, et al.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762–769.

    Article  PubMed  CAS  Google Scholar 

  3. Nishizawa H, Shimomura I, Kishida K, et al.: Androgens decrease plasma adiponectin, insulin sensitizing adipocyte derived protein. Diabetes 2002, 51:2734–2741.

    Article  PubMed  CAS  Google Scholar 

  4. Weyer C, Funahashi T, Tanaka S, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930–1935.

    Article  PubMed  CAS  Google Scholar 

  5. Hara K, Boutin P, Mori Y, Tobe K, et al.: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536–540.

    Article  PubMed  CAS  Google Scholar 

  6. Monzillo LU, Hamdy O, Horton ES, et al.: Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003, 11:1048–1054.

    Article  PubMed  CAS  Google Scholar 

  7. Maeda N, Takahashi M, Funahashi T, et al.: PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose derived protein. Diabetes 2001, 50:2094–2099.

    Article  PubMed  CAS  Google Scholar 

  8. Schubert UK, Kaplan RC, Rood J, Scherer PE: The serum adiponectin response to rosiglitazone in type 2 diabetes is not affected by co-administration of glyburide or metformin. Diabetes 2003, 52(snsuppl 1):A543.

    Google Scholar 

  9. Ouchi N, Kihara S, Arita Y, et al.: Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-Kappa B signaling through a camp dependent pathway. Circulation 2000, 102:1296–1301.

    PubMed  CAS  Google Scholar 

  10. Yokota T, Oritani K, Takahashi I, et al.: Adiponectin, a new member of the family of soluble defense collagens, negatively regulated the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723–1732.

    PubMed  CAS  Google Scholar 

  11. Matsuda M, Shimomura I, Sata M, et al.: Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J Biol Chem 2002, 277:37487–37491.

    Article  PubMed  CAS  Google Scholar 

  12. Wauters M, Considine RV, Yudkin JS, et al.: Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res 2003, 35:92–96.

    Article  PubMed  CAS  Google Scholar 

  13. Peterson KF, Oral EA, Dufour S, et al.: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002, 109:1345–1350.

    Article  CAS  Google Scholar 

  14. Park KG, Park KS, Kim MJ, et al.: Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004, 63:135–142.

    Article  PubMed  CAS  Google Scholar 

  15. Hamdy O, Horton ES: Effect of weight reduction and moderate intensity exercise on TNF-alpha in obese subjects with and without diabetes. Diabetes 2004, 52(snsuppl 2):1726-P.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamdy, O. The role of adipose tissue as an endocrine gland. Curr Diab Rep 5, 317–319 (2005). https://doi.org/10.1007/s11892-005-0086-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0086-0

Keywords

Navigation